It could also cause people to choose lower-fat, less energy-dense foods
The drug activates THR, a nuclear hormone receptor predominantly expressed in the liver and acts as a key regulator of metabolic pathways in this organ
Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, et al
Maintenance phases may drop to 2x/week (1 mg/week total)
GLP-1s are approved for weight loss in adults who have a body mass index of 30 or higher, and those who are overweight with a body mass index of 27 or higher with at least one weight-related health condition such as high blood pressure, high cholesterol and type 2 diabetes
These findings relate to investigational clinical research and should not be interpreted as evidence supporting the use of this laboratory research product in humans